Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2002

View Archived Issues

Aviron now part of MedImmune, expanding pipeline

Clinical testing of potentially safer amlodipine isomer begins at Sepracor

Clarinex tablets now available in U.S. pharmacies for SAR

Eos and Pharmacopeia decide not to merge

Prous Science announces new internet publication --Drug R&D Backgrounders: Sepsis and Septic Shock

QUATRx: a new biopharmaceutical company focusing on drugs targeting nuclear receptors

Another milestone reached in Celera Genomics/Aventis collaboration on cathepsin S inhibitors

Prana completes clinical stage of phase II Alzheimer's trial

MVA-Muc1-IL-2 enters phase II trials in lung and breast cancers

Single-dose EPI-2010 reduces need for bronchodilator medication in asthma patients

Nabi and Cankat sign Nabi-HB distribution agreement for Turkish market

Antibody research collaboration signed by Xenerex and DNAX Research

Merck's European C225 program progresses as planned despite U.S. setback

Frovatriptan completes mutual recognition procedure for E.U.-wide approval

Pieris and CytoTools collaborate to discover human Anticalins for atherosclerosis

Patient enrollment completed in trial of G17DT in gastric cancer

FDA approval granted for Eligard 7.5 mg, formerly Leuprogel One-Month Depot

TransDerm Technologies and Virotek to develop rapid lead poisoning detection test

Cognishunt system enters pivotal trials in AD patients

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Pyrazolotriazolopyrimidine derivatives with use in neurological diseases

Peptides with affinity for erythropoietin receptors useful in neurodegenerative disorders

Novel TNF-alpha production inhibitors identified at Santen

Sepracor scientists synthesize the four diastereomers of a piperidinyl-containing propionamide

Cell adhesion inhibitors described in patent by Tanabe Seiyaku

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...